New potential checkpoint inhibitors in cancer therapy

Article Properties
Cite
Kopecký, Jindřich. “New Potential Checkpoint Inhibitors in Cancer Therapy”. Onkologie, vol. 16, no. 3, 2022, pp. 115-7, https://doi.org/10.36290/xon.2022.022.
Kopecký, J. (2022). New potential checkpoint inhibitors in cancer therapy. Onkologie, 16(3), 115-117. https://doi.org/10.36290/xon.2022.022
Kopecký J. New potential checkpoint inhibitors in cancer therapy. Onkologie. 2022;16(3):115-7.
Refrences
Title Journal Journal Categories Citations Publication Date
B7-H3 role in the immune landscape of cancer. Am J Clinical and Experimental Immunology
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
 2017
LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model Oncotarget 212 2015
10.1158/1535-7163.MCT-18-1376
Restoring Immune Function of Tumor-Specific CD4+ T Cells during Recurrence of Melanoma

 The Journal of Immunology
  • Medicine: Internal medicine: Specialties of internal medicine: Immunologic diseases. Allergy
 145 2013
10.1172/JCI31184